CUAMC
DAWN

China Universal Asset Management Company’s Day One Biopharmaceuticals DAWN Stock Holding History

China Universal Asset Management Company’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,331
Closed -$393K – 525
2026
Q1 		$393K Buy
18,331
+1,600
+10% +$22.5K 0.03% 281
2025
Q4 		$156K Sell
16,731
-1,224
-7% -$10.2K 0.01% 369
2025
Q3 		$127K Sell
17,955
-2,403
-12% -$16.5K 0.01% 369
2025
Q2 		$132K Buy
20,358
+28
+0.1% +$193 0.01% 341
2025
Q1 		$161K Sell
20,330
-1,053
-5% -$11.3K 0.02% 329
2024
Q4 		$271K Buy
21,383
+2,180
+11% +$30.3K 0.03% 305
2024
Q3 		$267K Buy
19,203
+8,935
+87% +$127K 0.03% 277
2024
Q2 		$141K Sell
10,268
-6,549
-39% -$95.8K 0.02% 276
2024
Q1 		$278K Buy
16,817
+6,750
+67% +$101K 0.04% 252
2023
Q4 		$147K Buy
10,067
+7,841
+352% +$95.1K 0.03% 241
2023
Q3 		$27.3K Buy
2,226
+1,262
+131% +$16.5K 0.01% 277
2023
Q2 		$11.5K Sell
964
-32
-3% -$418 ﹤0.01% 309
2023
Q1 		$13.3K Buy
996
+249
+33% +$4.86K ﹤0.01% 259
2022
Q4 		$16.1K Buy
747
+59
+9% +$1.21K 0.01% 189
2022
Q3 		$14K Buy
+688
New +$14.6K 0.01% 177

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

China Universal Asset Management Company's DAWN Position: Q2 2026 in Review

China Universal Asset Management Company sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 18,331 shares — an estimated $393K sold.

China Universal Asset Management Company first reported a position in DAWN in Q3 2022 and held it in 15 quarters. The position peaked at $393K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • China Universal Asset Management Company reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • China Universal Asset Management Company sold 18,331 Day One Biopharmaceuticals shares in Q2 2026, an estimated $393K.
  • China Universal Asset Management Company first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 15 quarters.
  • China Universal Asset Management Company's Day One Biopharmaceuticals position peaked at $393K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.